Form 4: Insider Jorey Chernett Increases Stake in TOI

Reporting person Jorey Chernett acquired 12,000 shares of The Oncology Institute, Inc. common stock at $4.75 per share.

Summary

• Jorey Chernett, a 10% owner of The Oncology Institute, Inc. (TOI), purchased 12,000 shares of common stock.
• The transaction occurred on June 4, 2026, at a price of $4.75 per share.
• Following this acquisition, the reporting person's total beneficial ownership increased to 10,579,858 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it reflects a major shareholder increasing their position, suggesting confidence in the company's direction.

Positives

• Insider confidence is demonstrated by the purchase of 12,000 shares at $4.75 per share.
• The reporting person maintains a significant long-term stake of over 10.5 million shares.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal regarding management's or major shareholders' belief in the company's intrinsic value and future prospects within the oncology services sector.

Comparison to Industry Standards

• Insider buying at this scale is consistent with standard capital allocation behavior for significant stakeholders in small-cap healthcare firms.

Stakeholder Impact

• Shareholders may interpret this purchase as a sign of stability and confidence from a major stakeholder.

Next Steps

• NA

Key Dates

Keywords

TOI, The Oncology Institute, Insider Trading, Form 4, Stock Purchase